Articular cartilage extracellular matrix and chondrocytes

Articular cartilage is a highly specialized connective tissue found in synovial joints, characterized by a dense extracellular matrix (ECM) and a sparse population of resident cells known as chondrocytes. The ECM is primarily composed of a network of type II collagen fibers that provide tensile strength and large aggregating proteoglycans, such as aggrecan, which retain water to provide compressive resilience [1]. Chondrocytes are the sole cell type in this tissue and are responsible for maintaining the structural integrity of the matrix by balancing the synthesis of new components with the degradation of damaged ones [2]. In degenerative conditions like osteoarthritis, this homeostatic balance is lost, leading to the progressive breakdown of the ECM by enzymes like matrix metalloproteinases (MMPs) and the eventual death of chondrocytes [3]. Therapeutic interventions targeting this system focus on viscosupplementation to restore lubrication, growth factors to stimulate chondrocyte proliferation, or small molecules to inhibit inflammatory and catabolic signaling pathways [4]. Because articular cartilage is avascular and aneural, it possesses a very limited capacity for self-repair, making it a challenging yet critical focus for regenerative medicine and drug development [1][2]. Sources: [1] Sophia Fox AJ, et al. (2009). The basic science of articular cartilage: structure, composition, and function. Sports Health. [2] Akhtar S, et al. (2021). Extracellular Matrix of Articular Cartilage. Frontiers in Bioscience. [3] Mobasheri A, et al. (2017). The articular chondrocyte: an explainer. Osteoarthritis and Cartilage. [4] Kraus VB, et al. (2015). Focus on biomarkers in osteoarthritis. NIH Public Access.

Other names

Hyaline cartilageCartilage matrixChondrogenic tissueJoint cartilage

Promotion of chondrocyte anabolic activity via growth factor signaling (e.g., FGFR3), inhibition of catabolic enzymes such as matrix metalloproteinases (MMPs) and ADAMTS, restoration of synovial fluid viscoelasticity, and modulation of Wnt signaling pathways to prevent chondrocyte hypertrophy.